Retinoblastoma future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
(2 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Retinoblastoma}} | {{Retinoblastoma}} | ||
==Overview== | |||
Patients who have been treated with radiation are at higher risk for secondary tumors in the field of treatment.<ref>http://eyewiki.org/Retinoblastoma#Follow_up</ref> | |||
==References== | ==References== | ||
Line 17: | Line 19: | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:hereditary cancers]] | [[Category:hereditary cancers]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Ophthalmology]] |
Latest revision as of 15:23, 27 November 2017
Retinoblastoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Retinoblastoma future or investigational therapies On the Web |
American Roentgen Ray Society Images of Retinoblastoma future or investigational therapies |
Retinoblastoma future or investigational therapies in the news |
Risk calculators and risk factors for Retinoblastoma future or investigational therapies |
Overview
Patients who have been treated with radiation are at higher risk for secondary tumors in the field of treatment.[1]